NCT00476424View on ClinicalTrials.gov

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
HIV Infections
Interventions
DRUG

efavirenz

EFV 400 mg OD for 14 days EFV 600 mg OD for 14 days

Trial Locations (1)

10330

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok

All Listed Sponsors
collaborator

Ministry of Education, Thailand

OTHER

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

NCT00476424 - A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects | Biotech Hunter | Biotech Hunter